UCLA: UCLA Scientists Make Strides Toward An ‘Off-The-Shelf' Immune Cell Therapy For Cancer

Press release from UCLA:

Tiare Dunlap

November 16, 2021

Using stem cell engineering and organoid technology, researchers produce large quantities of powerful cancer-fighting iNKT cells Using stem cell engineering and organoid technology, researchers produce large quantities of powerful cancer-fighting iNKT cells Yang says she hopes this advance will better enable mass-production of the therapy and, ultimately, its clinical and commercial development.

This press release was produced by UCLA. The views expressed here are the author’s own.